Advisory Commission on Childhood Vaccines; Notice of Meeting, 9010 [E7-3559]

Download as PDF 9010 Federal Register / Vol. 72, No. 39 / Wednesday, February 28, 2007 / Notices Number of respondents Regulation citation 60.11(a)(7) Requests by Researchers for Aggregated Data ...................... 60.14(b) Practitioner Places a Report in Disputed Status .......................... 60.14(b) Practitioner Statement ................................................................... 60.14(b) Practitioner Requests for Secretarial Review ............................... 60.3 Entity Registration—Initial ................................................................... 60.3 Entity Registration—Update ................................................................ 60.11(a) Authorized Agent Designation—Initial .......................................... 60.11(a) Authorized Agent-Update .............................................................. 60.12(c) Account Discrepancy Report ......................................................... 60.12(c) Electronic Funds Transfer Authorization ....................................... 60.3 Entity Reactivation ............................................................................... 100 666 2,563 117 500 643 500 86 300 363 100 Total ...................................................................................................... ........................ Hours per response (minutes) Frequency of responses 1 1 1 1 1 1 1 1 1 1 1 .......................... Total burden hours 30 5 45 480 60 5 15 5 15 15 60 50 55 1,922 936 500 54 125 7 75 91 100 ........................ 293,644 Numbers in the table may not add up exactly due to rounding. Send comments to Susan Queen, PhD, HRSA Reports Clearance Officer, Room 10–33, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Written comments should be received within 60 days of this notice. Dated: February 22, 2007. Alexandra Huttinger, Acting Director, Division of Policy Review and Coordination. [FR Doc. E7–3446 Filed 2–27–07; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission on Childhood Vaccines; Notice of Meeting sroberts on PROD1PC70 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: March 7, 2007, 1 p.m.–5 p.m., EST. March 8, 2007, 9 a.m.–3:30 p.m., EST. Place: Audio Conference Call and Parklawn Building, Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857. The ACCV will meet on Wednesday, March 7, from 1 p.m. to 5 p.m., and on Thursday, March 8, from 9 a.m. to 3:30 p.m. The public can join the meeting in person at the address listed above or by audio conference call by dialing 1–888–947–9967 on March 7 and 8 and providing the following information: Leader’s Name: Dr. Geoffrey Evans. Password: ACCV. Agenda: The agenda items for the March meeting will include, but are not limited to: A discussion of VICP outreach activities; an overview of the Vaccine Adverse Event Reporting System, including the requirements for the reporting of adverse events; a report from the ACCV Futures Workgroup; and updates from the Division of VerDate Aug<31>2005 17:43 Feb 27, 2007 Jkt 211001 Vaccine Injury Compensation (DVIC), Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics and Evaluation Research (Food and Drug Administration). Agenda items are subject to change as priorities dictate. Public Comments: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation, to: Ms. Cheryl Lee, Principal Staff Liaison, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857 or e-mail: clee@hrsa.gov. Requests should contain the name, address, telephone number, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the comment period. These persons will be allocated time as it permits. For Further Information Contact: Anyone requiring information regarding the ACCV should contact Ms. Cheryl Lee, Principal Staff Liaison, DVIC, HSB, HRSA, Room 11C– 26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443–2124 or e-mail: clee@hrsa.gov. Notification: Due to inclement weather, the requirement that the public be notified of this meeting at least 15 calendar days in advance was not met. Dated: February 22, 2007. Alexandra Huttinger, Acting Director, Division of Policy Review and Coordination. [FR Doc. E7–3559 Filed 2–27–07; 8:45 am] BILLING CODE 4165–15–P PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; Comment Request; Request for Genetic Studies in a Cohort of U.S. Radiologic Technologists SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Cancer Institute, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request to review and approve the information collection listed below. This proposed information collection was previously published in the Federal Register on December 29, 2006, pages 78445–78446 and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Proposed Collection Title: Genetic Studies in a Cohort of U.S. Radiologic Technologists (formerly known as ‘‘Generic Clearance to Collect Medical Outcome and Risk Factor Data from a Cohort of U.S. Radiologic Technologists’’). Type of Information Collection Request: Renewal with change of a previously approved collection (OMB No. 0925–0405, expiration 02/28/2007). Need and Use of Information Collection: The primary aim of this collection is to substantially increase knowledge about the possible modifying role of genetic variation on the long-term health effects associated with protracted low-to moderate-dose E:\FR\FM\28FEN1.SGM 28FEN1

Agencies

[Federal Register Volume 72, Number 39 (Wednesday, February 28, 2007)]
[Notices]
[Page 9010]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-3559]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: March 7, 2007, 1 p.m.-5 p.m., EST. March 8, 2007, 
9 a.m.-3:30 p.m., EST.
    Place: Audio Conference Call and Parklawn Building, Conference 
Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
    The ACCV will meet on Wednesday, March 7, from 1 p.m. to 5 p.m., 
and on Thursday, March 8, from 9 a.m. to 3:30 p.m. The public can 
join the meeting in person at the address listed above or by audio 
conference call by dialing 1-888-947-9967 on March 7 and 8 and 
providing the following information:
    Leader's Name: Dr. Geoffrey Evans.
    Password: ACCV.
    Agenda: The agenda items for the March meeting will include, but 
are not limited to: A discussion of VICP outreach activities; an 
overview of the Vaccine Adverse Event Reporting System, including 
the requirements for the reporting of adverse events; a report from 
the ACCV Futures Workgroup; and updates from the Division of Vaccine 
Injury Compensation (DVIC), Department of Justice, National Vaccine 
Program Office, Immunization Safety Office (Centers for Disease 
Control and Prevention), National Institute of Allergy and 
Infectious Diseases (National Institutes of Health), and Center for 
Biologics and Evaluation Research (Food and Drug Administration). 
Agenda items are subject to change as priorities dictate.
    Public Comments: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation, to: Ms. Cheryl Lee, Principal Staff Liaison, 
DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services 
Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville, MD 
20857 or e-mail: clee@hrsa.gov. Requests should contain the name, 
address, telephone number, and any business or professional 
affiliation of the person desiring to make an oral presentation. 
Groups having similar interests are requested to combine their 
comments and present them through a single representative. The 
allocation of time may be adjusted to accommodate the level of 
expressed interest. DVIC will notify each presenter by mail or 
telephone of their assigned presentation time. Persons who do not 
file an advance request for a presentation, but desire to make an 
oral statement, may announce it at the time of the comment period. 
These persons will be allocated time as it permits.
    For Further Information Contact: Anyone requiring information 
regarding the ACCV should contact Ms. Cheryl Lee, Principal Staff 
Liaison, DVIC, HSB, HRSA, Room 11C-26, 5600 Fishers Lane, Rockville, 
MD 20857; telephone (301) 443-2124 or e-mail: clee@hrsa.gov.
    Notification: Due to inclement weather, the requirement that the 
public be notified of this meeting at least 15 calendar days in 
advance was not met.

    Dated: February 22, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review and Coordination.
 [FR Doc. E7-3559 Filed 2-27-07; 8:45 am]
BILLING CODE 4165-15-P